Mark O. Wielpütz

Mar 28, 2024 | erj.ersjournals.com | Mark O. Wielpütz |Marcus A. Mall

Footnotes Conflict of interest: M.A. Mall reports grants from German Ministry for Education and Research (BMBF), German Research Foundation (DFG), German Innovation Fund and Vertex Pharmaceuticals, consultancy fees from Abbvie, Antabio, Arrowhead, Boehringer Ingelheim, Enterprise Therapeutics, Kither Biotec, Prieris, Recode, Santhera, Splisense and Vertex Pharmaceuticals, lecture honoraria from Vertex Pharmaceuticals, travel support from Boehringer Ingelheim and Vertex Pharmaceuticals,...